The broadly neutralizing 2F5 and 4E10 monoclonal antibodies (MAbs) recognize epitopes within the membrane-proximal external region (MPER) that connects the human immunodeficiency virus type 1 (HIV-1) envelope gp41 ectodomain with the transmembrane anchor. By adopting different conformations that stably insert into the virion external membrane interface, such as helical structures, a conserved aromatic-rich sequence within the MPER is thought to participate in HIV-1-cell fusion. Recent experimental evidence suggests that the neutralizing activity of 2F5 and 4E10 might correlate with the MAbs' capacity to recognize epitopes inserted into the viral membrane, thereby impairing MPER fusogenic activity. To gain new insights into the molecular mechanism underlying viral neutralization by these antibodies, we have compared the capacities of 2F5 and 4E10 to block the membrane-disorganizing activity of MPER peptides inserted into the surface bilayer of solution-diffusing unilamellar vesicles. Both MAbs inhibited leakage of vesicular aqueous contents (membrane permeabilization) and intervesicular lipid mixing (membrane fusion) promoted by MPER-derived peptides. Thus, our data support the idea that antibody binding to a membrane-inserted epitope may interfere with the function of the MPER during gp41-induced fusion. Antibody insertion into a cholesterol-containing, uncharged virion-like membrane is mediated by specific epitope recognition, and moreover, partitioning-coupled folding into a helix reduces the efficiency of 2F5 MAb binding to its epitope in the membrane. We conclude that the capacity to interfere with the membrane activity of conserved MPER sequences is best correlated with the broad neutralization of the 4E10 MAb.
It is generally accepted that a potentially successful human immunodeficiency virus (HIV) vaccine should be capable of eliciting a robust neutralizing antibody (NAb) response (15, 16) . The isolation from infected asymptomatic individuals of several antibodies showing neutralizing activity against a broad spectrum of viral clades implies that triggering such an immunogenic response might conceivably be possible (15, 16, 74) . The anti-gp41 2F5 and 4E10 monoclonal antibodies (MAbs) constitute a paradigm in this respect (21, 34, 48, 49, 56, 68) . These MAbs simultaneously exert broad and potent neutralizing activity across different HIV type 1 (HIV-1) strains and primary isolates (9, 34, 45, 48, 68, 89) , confer protection against viral infection when passively transferred to primate models (67) , and increase the neutralization response upon passive immunization of humans (66, 74) . Thus, deciphering the molecular mechanisms underlying viral cross-neutralization by 2F5 and 4E10 poses a challenge for researchers working on HIV vaccine development (86) .
2F5 and 4E10 recognize conserved linear epitopes located within the membrane-proximal external region (MPER) of the HIV-1 gp41 fusogenic Env subunit (7, 18, 19, 34, 48, 49, 51, 54, 89) . The crystal structures of the 2F5 and 4E10 Fabs in a complex with soluble epitope derivatives have been resolved (13, 18, 19, 51) , revealing long complementarity-determining region H3s containing solvent-exposed aromatic residues. Aromatic residues are the most hydrophobic-at-interface residues, and, as such, they are postulated to efficiently drive water-membrane partitioning (81, 83) , suggesting that these antibodies share a common adaptive trait for epitope recognition at the membrane surface (19, 51, 62) . Hydropathy plots calculated according to the Wimley-White (WW) scale (81) actually revealed a fully hydrophobic-at-interface sequence within gp41 MPER, previously termed the pretransmembrane domain (PreTM) (39, 50, 59, 70, 71) . Thus, the gp41 region spanning the 2F5 and 4E10 epitopes has a specific affinity for the membrane interface, the lipid bilayer region between the high-polarity water phase and the low-polarity hydrocarbon core (79) .
Subsequent development of WW scale applications, including the simultaneous computation of interfacial affinity and hydrophobic moments (38, 58) , revealed that the MPER was segmented into two subdomains, a phenomenon that was pro-posed to be functionally meaningful (58) . These analyses predicted the existence of a helical, conserved amphipathic-atinterface sequence (AIS), located at the amino-terminal end of PreTM, which would be followed by a fully hydrophobic-atinterface stretch (Fig. 1) . The solved Fab structures in complex with epitope-representing peptides revealed the sequences in contact with 2F5 (657EQELLELDKWASLW670) and 4E10 (672WFNITNWLW680) paratopes (18, 51) . Thus, the full 2F5 epitope roughly corresponds to the AIS, while the 4E10 epitope starts at the junction between the subdomains and ends close to the PreTM C terminus (Fig. 1A) .
Recent structural characterization by Sun et al. (72) combining nuclear magnetic resonance (NMR) and electron paramagnetic resonance spectroscopy supported this predicted membrane topology. Indeed, these data confirmed that an MPER-derived peptide adopts a bipartite membrane structure, consisting of a tilted amphipathic N-terminal helix (residues 664 to 672) connected via a short hinge to a C-terminal helix (residues 675 to 683) mostly embedded in the membrane interface (Fig. 1B) . The peptide analyzed by these authors spanned residues 662 to 683, slightly longer than the PreTM (residues 664 to 683), and it did not include the complete AIS (residues 656 to 671; Fig. 1A ). Mutagenesis studies and biophysical characterization of representative peptides further suggest an active role for MPER in gp41-mediated fusion (24, 25, 39, 47, 59, 60, 64, 65, (70) (71) (72) 76) , by transmitting protein conformational energy into the virion membrane and/or by perturbing its integrity (Fig. 1B,  left) . Cryoelectron tomography analysis of intact simian immunodeficiency virus virions supports the notion that membraneinserted MPER sequences may indeed represent relevant native gp41 structures (57, 85) . Thus, the neutralization efficiency of the 2F5 and 4E10 MAbs may conceivably be dependent on their capacity to bind membrane-inserted MPER sequences and subsequently interfere with their membrane-disorganizing activity during the fusion reaction cycle (Fig. 1B, right ). Here, we tested this hypothesis by comparing the in-membrane recognition and blocking activities of the 2F5 and 4E10 MAbs. We have used solution-diffusing, unstressed phospholipid vesicles with sizes that approximate that of the HIV virion (i.e., with a comparable bilayer intrinsic curvature) and an MPERderived sequence (AISpreTM) that combines the full-length 2F5 and 4E10 epitopes (13, 18, 51, 54) . The apparent inmembrane MAb-epitope binding parameters were inferred from the inhibition of peptide-induced leakage and fusion in this intact system (i.e., without separating or diluting bound and unbound species). Together with direct electron microscopy and flow cytometry determination of the vesicle-antibody association, the inhibition data defined a comparatively lower affinity of the 2F5 MAb for membrane-bound species.
MATERIALS AND METHODS

Materials.
The sequences AISpreTM, AISpreTM(9, 10)A, AISpreTM (17, 18) , AIS, and PreTM displayed in Fig. 1A were synthesized as C-terminal carboxamides by solid-phase synthesis using Fmoc chemistry, and they were purified by high-performance liquid chromatography at the Proteomics Unit of the University Pompeu-Fabra (Barcelona, Spain). Peptide stock solutions were prepared in dimethyl sulfoxide (spectroscopy grade), and the concentrations were determined using a bicinchoninic acid microassay (Pierce, Rockford, IL). NAbs expressing hybridomas were originally generated by combined polyethylene glycol electrofusion of peripheral blood mononuclear cells from HIV-infected nonsymptomatic patients (14) . The 2F5 and 4E10 MAbs used in this study were subsequently produced in recombinant CHO cells after the subclass switch to immunoglobulin G1 (IgG1) (33). 1-Palmitoyl-2-oleoylphosphatidylcholine (POPC) and cholesterol (Chol) were purchased from Avanti Polar Lipids (Birmingham, AL), while dodecylphosphocholine (DPC) was from Anatrace (Maumee, OH). The N- (7- 
-trisulfonic acid sodium salt (ANTS), and p-xylenebis(pyridinium)bromide (DPX) fluorescent probes were from Molecular Probes (Junction City, OR), while the PE-Cy5 mouse anti-human IgG was purchased from BD Biosciences.
Infrared spectroscopy. Infrared spectra were recorded at 25°C in a Bruker Tensor 27 spectrometer equipped with a mercury-cadmium-telluride detector FIG. 1. Gp41 MPER sequence, derived peptides, and predicted membrane effects. (A) Membrane-proximal and transmembrane sequences of the HIV-1 gp41 integral subunit (sequence and numbering are derived from the prototypic HXBc2 isolate). The gray continuous line represents the average hydropathy plot calculated for a window of 5 amino acids using the WW hydrophobicity scale at membrane interfaces (81) . The red dotted line is the mean WW moment (window of 11 amino acids) calculated for a fixed ␦ of 100°(helical periodicity) and hydrophobicity-at-interface scale (58) . Full 2F5 and 4E10 epitopes are shown in red and green, respectively. Residues belonging to the transmembrane domain are shown in blue. The box below displays the peptide sequences used in this study. MPER designates the peptide used by Sun et al. (72) . (B, left) Predicted membrane topology for the sequences depicted in panel A. The MPER 656-to-683 region is shown to consist of two segments: an amphipathic sequence (red) followed by a fully interfacial stretch (green). The tilt of the N-terminal amphipathic helix is based on the bipartite NMR structure observed in DPC micelles (72) . Insertion of this interfacial element into the external monolayer of the virion membrane might be required to disrupt interactions between lipid molecules and be directly involved in the destabilization of membrane integrity. The differential-surface increase of the external membrane monolayer might also contribute to membrane deformation and thinning. (Right) Extraction of the epitope sequences by 2F5 or 4E10 would result in bilayer architecture stabilization, thereby interfering with fusion. (4) (5) (6) .
Production of vesicles. Large unilamellar vesicles (LUV) were prepared by following the extrusion method of Hope et al. (29) . Phospholipids and Chol were mixed in chloroform and dried under an N 2 stream. Traces of organic solvent were removed by overnight vacuum pumping. Subsequently, the dried lipid films were dispersed in 5 mM HEPES-100 mM NaCl (pH 7.4) buffer and subjected to 10 freeze-thaw cycles prior to extrusion 10 times through two stacked polycarbonate membranes (Nuclepore, Inc., Pleasanton, CA). The size distributions of the vesicles were determined using a Zeta-Sizer Nano ZS instrument (Malvern Instruments, Malvern, United Kingdom). Extrusion through membranes with nominal pore sizes of 0.1 and 0.2 m produced POPC-Chol (2:1, mol/mol) LUV with mean diameters (Ϯ standard deviations) of 90 Ϯ 17 and 132 Ϯ 36 nm, respectively. Lipid concentrations of liposome suspensions were determined by phosphate analysis.
Fluorimetric assays. Peptide partitioning into membranes was evaluated by monitoring the change in the emitted Trp fluorescence. Corrected spectra were recorded using an SLM Aminco 8100 spectrofluorimeter (Spectronic Instruments, Rochester, NY) with excitation set at 280 nm and 5-nm slits. Partitioning curves were subsequently computed from the fractional changes in emitted Trp fluorescence when peptides were titrated with lipids at increasing concentrations. The signal was further corrected for dilution and inner filter effects (80) using NATA (N-acetyl-L-tryptophanamide), a soluble Trp analogue that does not partition into the membranes. The apparent mole fraction partition coefficients, K x , were determined by fitting the experimental values to the hyperbolic function 
where R is the universal gas constant and T is temperature. The release of vesicular contents into the medium was monitored by the ANTS/DPX assay (23) . LUV containing 12.5 mM ANTS, 45 mM DPX, 20 mM NaCl, and 5 mM HEPES were obtained by separating the unencapsulated material by gel filtration on a Sephadex G-75 column eluted with 5 mM HEPES and 100 mM NaCl (pH 7.4). Osmolarities were adjusted to 200 mosM in a cryoscopic osmometer (Osmomat 030; Gonotec, Berlin, Germany). Fluorescence measurements were performed by setting ANTS emission at 520 nm and excitation at 355 nm. A cutoff filter (470 nm) was placed between the sample and the emission monochromator. Zero percent leakage corresponded to the fluorescence of the vesicles at time zero, whereas 100% leakage was the fluorescence value obtained after addition of Triton X-100 (0.5%, vol/vol).
Partitioning into the membrane interface as a function of time was determined by measuring energy transfer from the Trp peptide to the surface d-DHPE fluorescent probe as in reference 37. In brief, 6 mol% of the d-DHPE probe was included in the target vesicle composition, and its fluorescence was measured at an emission wavelength of 510 nm, while the excitation wavelength was that of the Trp residue (280 nm). Membrane lipid mixing was monitored using the resonance energy transfer assay described by Struck et al. (69) . The assay is based on the dilution of N-NBD-PE and N-Rh-PE, whereby dilution due to membrane mixing results in increased N-NBD-PE fluorescence. Vesicles containing 0.6 mol% of each probe were mixed with unlabeled vesicles at a ratio of 1:4 (final lipid concentration, 0.1 mM). The NBD emission was monitored at 530 nm, with the excitation wavelength set at 465 nm. A cutoff filter at 515 nm was used between the sample and the emission monochromator to avoid scattering interference. The fluorescence scale was calibrated such that the zero level corresponded to the initial residual fluorescence of the labeled vesicles and the value of 100% corresponded to the complete mixing of all the lipids in the system. The latter value was set by the fluorescence intensity of vesicles labeled with 0.12 mol% of each fluorophore at the same total lipid concentration as in the fusion assay.
Monolayer penetration. Surface pressure was determined in a fixed-area circular trough (Trough S system; Kibron, Helsinki, Finland), and the measurements were taken at room temperature with constant stirring in an aqueous phase consisting of 1 ml 5 mM HEPES and 100 mM NaCl (pH 7.4). Lipid mixtures dissolved in chloroform were spread over the surface, and the desired initial surface pressure ( 0 ) was attained by changing the amount of lipid applied to the air-water interface. Peptide was injected into the subphase with a Hamilton microsyringe. At the concentrations used, the peptide alone induced only a negligible increase in surface pressure at the air-water interface.
Enzyme-linked immunosorbent assay (ELISA). Peptides were dissolved in phosphate-buffered saline and immobilized (100 l/well) overnight in C96 Maxisorp microplate wells (Nunc, Denmark) at a concentration of 1 M. Prior to incubation with the MAbs, the plates were blocked for 2 h with 3% (wt/vol) bovine serum albumin in phosphate-buffered saline. The binding of the MAbs was detected with an alkaline phosphatase-conjugated goat anti-human immunoglobulin (Pierce, Rockford, IL), which then catalyzed a color reaction with the p-nitrophenylphosphate substrate (Sigma, St. Louis, MO) that could be determined by measuring the absorbance at a wavelength of 405 nm in a Synergy HT microplate reader (Bio-TEK Instruments Inc., VT).
Electron microscopy. Experimental evidence for stable antibody-vesicle association was initially obtained by electron microscopy. Liposome-MAb samples were prepared by following a protocol analogous to that used for the cytometric analysis (see below). Samples were subsequently incubated on copper grids for 2 min, dried, and finally stained for 1 min with 2% uranyl acetate. Electron micrographs were obtained using a JEOL 1200EX II microscope operated at 100 kV and recorded on Kodak SO-163 film.
Flow cytometry. Antibody-vesicle association was also determined quantitatively using a FACSCalibur flow cytometer (Becton Dickinson Immunocytometry Systems, Mountain View, CA). Measuring conditions were initially optimized by attending to the following experimental parameters: (i) vesicle size (LUV extruded through polycarbonate filters with nominal sizes of 100, 200, 400 and 1,000 nm and multilayered vesicles were compared), (ii) lipid concentration in the samples, and (iii) percentage of fluorescent probe in the membrane tested with 1, 0.1, 0.01, and 0.001 mol of f-DHPE. The optimal conditions were set for LUV obtained through extrusion using filters with a nominal pore size of 200 nm, a lipid concentration of 0.25 mM, and 0.01 mol% fluorescent phospholipid probe. Thus, in a typical experiment fluorescently labeled vesicles doped with peptide epitopes (1:100 peptide/lipid molar ratio) were incubated for 10 min with increasing concentrations of the 2F5 or 4E10 MAbs and, subsequently, for 5 min with twice the concentration of anti-human IgG coupled to cyanine (IgG-PE-Cy5).
RESULTS
Partitioning of AISpreTM into membranes: structure and energetics. The aim of this study was to compare the abilities of the 2F5 and 4E10 MAbs to recognize complete membraneinserted epitopes. Thus, the AISpreTM boundaries (residues 656 to 683) were defined as containing the full-length 2F5 and 4E10 epitopes, as well as both interfacial subdomains (Fig.  1A) . The intrinsic capacity of the designed AISpreTM sequence to translocate into membranes and fold therein was first analyzed based on the sequence's amino acid composition (Table 1) . Water-to-membrane interface transfer free energies for all amino acids have been determined by Wimley and White (79, 81) . These values reflect real thermodynamic measurements compiling the energetic components that dictate the initial partitioning of unfolded peptide sequences into membranes. Furthermore, they are additive, which allows computation of the energetics of partitioning for arbitrary protein sequences. Computation of the overall free energies of partitioning for the unfolded AISpreTM and PreTM sequences rendered values on the order of Ϫ2.8 and Ϫ8.1 kcal/mol, respectively (Table 1 ). In accordance with equation 1 (Materials and Methods), these values corresponded to partitioning constants (K x ) on the order of 10 2 and 10 6 , which reflects the much higher solubility or reduced membrane affinity of the AISpreTM sequence in comparison to that of PreTM. Those K x values actually predicted that AISpreTM partitioning would be insignificant at lipid concentrations that would otherwise permit substantial PreTM-membrane association (e.g., more than 60% of the added peptide at a lipid concentration of 100 M).
However, C ␣ chain polarity may be reduced upon folding as an ␣-helix, which results in an increase of interfacial hydrophobicity (35, 78) . Free energies of partitioning recalculated taking into account this conformational energy rendered K x values higher than 10 7 in both cases, consistent with the quantitative incorporation of PreTM and AISpreTM into membranes. Thus, from the sequence it can be inferred that decreasing the C ␣ chain polarity by adopting a defined secondary structure is a prerequisite for the efficient incorporation of AISpreTM into vesicles (35, 78, 79) . In contrast, the free energy values computed for the AIS predicted that this gp41 stretch alone would not associate with the membrane interface even if it adopted an ␣-helix structure (Table 1 ). This implies that the embedding of the complete 2F5 epitope into the membrane interface would require its folding into an ␣-helix, as well as extending the sequence at its C terminus to include the aromatic PreTM residues.
Thus, we next set out to assess experimentally the structure adopted by AISpreTM in a membrane environment and to explore the conditions that permit the efficient incorporation of the peptide from water into lipid bilayers (see Fig. S1 and S2 and Table S1 in the supplemental material). Quantitative infrared spectroscopy determinations were indeed consistent with the helical structuring of the 2F5 and 4E10 epitopes in the context of membrane-bound AISpreTM. Decomposition of the amide I bands of PreTM and AISpreTM confirmed that these peptides adopted very similar secondary structures in DPC micelles (see Fig. S1 and Table S1 in the supplemental material). In both cases the ␣-helical conformation was predominant, although its contribution was slightly higher in the AISpreTM sequence. By contrast, the AIS peptide amide I band could not be fitted to a major component, consistent with the absence of a single main secondary structure. In this case, a strong contribution of unordered structures coexisted with a mixture of canonical structures. Notably, bands that could be assigned to ␤-turns and/or 3 10 -helices contributed to the same extent as ␣-helices and ␤-sheet bands. Thus, these infrared spectroscopy results confirmed that the conformational plasticity previously reported for peptides representing the extended 2F5 epitope (7, 10) was maintained in the nonpolar environment provided by DPC micelles. Moreover, they also suggested that this flexible sequence was constrained into a main ␣-helical structure when anchored to the membrane interface as a part of AISpreTM.
We next analyzed experimentally AIS and AISpreTM membrane association (see Fig. S2 in the supplemental material) . The monolayer insertion results reflected exclusion pressures (levels of lateral compression precluding insertion) of 43 and 28 mN m Ϫ1 for AISpreTM and AIS, respectively, indicating that AISpreTM was capable of penetrating into comparatively more packed lipid bilayers (see Fig. S2A in the supplemental material). Moreover, while AISpreTM and PreTM clearly inserted at above the lateral pressures existing in biological membranes ( 0 Ն 30 to 35 mN m Ϫ1 ; Table 1 ), it was predicted that AIS was devoid of the capacity for inserting into lipid bilayers that are not expanded artificially (40) . These observations were further confirmed by measurements of peptide insertion into LUV (see Fig. S2B in the supplemental material). LUV lipid bilayers are compressed to lateral pressures in the range of those existing in natural membranes, and, therefore, peptides showing exclusion pressures below 30 mN m Ϫ1 are predicted not to insert into these vesicles. AISpreTM insertion into LUV bilayers could be deduced from the changes in the fluorescence Trp spectrum obtained upon titrating peptides with lipid vesicles (see Fig. S2B in the supplemental material). The polarity of the environment surrounding Trp residues decreased upon penetration of the peptide into the bilayer, which resulted in Trp fluorescence intensity enhancement and shifting of its maximum toward lower wavelengths in the presence of the vesicles (see Fig. S2B , left panel, in the supplemental material). The corresponding partitioning curve reflects the fraction of peptide bound to vesicles as the amount of lipid was augmented (see Fig. S2B , right panel, in the supplemental material). Fitting the experimental values to function (1) disclosed K x values higher than 10 7 for AISpreTM, in agreement with the free energy values calculated for a structured sequence (Table 1) . By contrast no changes in AIS Trp emission were detected in the presence of vesicles (see Fig. S2 in the supplemental material). Thus, the MPER AIS stretch alone displayed no significant affinity for membranes, while extending the sequence to include the complete PreTM augmented the interfacial affinity so as to produce almost complete incorporation into vesicles at lipid concentrations above 100 M (Ͼ95% of added peptide associated with membranes). Together, the results confirm that the AISpreTM sequence spontaneously inserts into electrically neutral vesicles, adopting an equilibrium ␣-helix structure therein.
The blocking of the AISpreTM-induced membrane restructuring by MAbs 2F5 and 4E10. In a previous paper we showed that Chol sustained the lytic and fusogenic activities of the PreTM peptide, as measured in a vesicular system (59) . Since the membrane activity of PreTM is preserved within the longer sequence, AISpreTM also altered the integrity of Chol-containing vesicles (Fig. 2A) . Indeed, there was extensive leakage of the aqueous contents from the vesicle in the presence of 1 M peptide (Ͼ60%), while comparable levels of membranelipid mixing required a dose four times higher. In these assays AISpreTM incorporation into vesicles as a function of time was fluorescently monitored using the membrane surface-an- (Fig. 2A) . By contrast and in accordance with the rearrangement of peptide monomers at the membrane surface (59), the kinetics of leakage and fusion were slower and both processes required several minutes to stabilize ( Fig. 2A) . The fast incorporation and slower membrane restructuring induced by AISpreTM allowed the capacities of MAbs 2F5 and 4E10 to block MPER membrane activity to be compared by assessing the effect of adding the MAbs on AISpreTM-induced leakage or fusion (Fig. 2B, top and bottom, respectively) . Accordingly, the peptide was added to a stirred solution of lipid vesicles (1) and the MAb was injected into the mixture after the peptide had incorporated into the vesicles according to the d-DHPE assay (2) . Consistent with the recognition of membrane-bound species under these conditions, the 4E10 MAb efficiently interfered with both leakage and fusion (right), whereas injection of similar doses of the 2F5 MAb had almost no effect on these processes (left).
The inhibition of membrane restructuring was dose dependent (Fig. 2C) , and the percentage of inhibition could be inferred from the sudden reductions in the kinetic slopes. For leakage (left), 50% inhibitory concentrations on the order of 30 and 200 nM were observed for the 4E10 and 2F5 MAbs, respectively, and thus, the 4E10 MAb was approximately 10 times more potent than the 2F5 MAb in inhibiting AISpreTMinduced leakage. The 50% inhibitory concentration for the inhibition of fusion was on the same order in the case of the 4E10 MAb, while the 2F5 MAb was unable to completely inhibit fusion within the concentration range tested. Thus, the difference in the capacity to inhibit AISpreTM-induced fusion was even higher.
Stable AISpreTM-mediated MAb-bilayer association. In order to confirm the in-membrane recognition of the inserted AISpreTM, we evaluated MAb-liposome association under comparable experimental conditions (i.e., stirred, diluted liposome samples). The existence of a stable association of the antibody with the surface of vesicles was first assessed by electron microscopy (Fig. 3) . Samples of control untreated POPCChol vesicles showed heavily stained membrane edges that clearly contrasted with the surrounding medium (Fig. 3A) , and a similar morphology was displayed by vesicles incubated with AISpreTM alone at concentrations that induced leakage from individual vesicles but not fusion (Fig. 3B) . However, incubation of these peptide-containing vesicles with the 4E10 (Fig.  3D and E) or 2F5 ( Fig. 3G and H ) MAb produced vesicles with electron-dense particles and punctate edges, which were consistent with antibody molecules protruding from the bilayer surface. These antibody particles could not be detected when POPC-Chol vesicles devoid of the peptide epitope were exposed to the MAbs (Fig. 3C and F) . Thus, the morphological data support a physical interaction of the MAbs with the lipid bilayer surrounding the vesicles in the presence of AISpreTM.
This association of the MAbs with the vesicles was next monitored by fluorescence-activated cell sorting (FACS) set up to simultaneously detect liposome and antibody fluorescent signals ( Fig. 4 ; see Materials and Methods). As judged from the appearance of a main antibody-stained vesicle population (Fig. 4A) , both Mabs efficiently associated with POPC-Chol vesicles that contained AISpreTM (Ͼ90% of the vesicles were labeled with fluorescent antibody upon incubation with 50 g/ml MAb). In contrast, when the MAbs were incubated under comparable conditions with POPC-Chol liposomes devoid of peptides, the antibody-stained vesicles constituted a minimal fraction (Ͻ5% of the vesicle population).
Hence, this flow cytometry analysis confirmed that AISpreTM mediated the stable association of MAbs with the lipid bilayer. As a consequence, we performed further cytometric measurements to quantitatively compare the capacities of both MAbs to stably associate with vesicles doped with AISpreTM (Fig.  4B) . These measurements served to ascertain whether the weaker inhibition induced by the 2F5 MAb was due to reduced binding or whether the binding of this MAb to AISpreTM did not effectively block membrane activity. Titration data confirmed that the 4E10 MAb associated with vesicles at lower concentrations (Fig. 4B) . Moreover, in both cases a population of MAb-stained vesicles could be recovered at the MAb concentrations that inhibited leakage. Together, these results support the notion that stable association of the 2F5 and 4E10 MAbs with peptide-containing POPC-Chol vesicles correlates with their capacity to inhibit AISpreTM-induced membrane restructuring.
Specificity of membrane-bound AISpreTM recognition and blocking. Our previous results are consistent with the in situ recognition and blocking of membrane-inserted AISpreTM, and, in addition, they suggest that the 4E10 MAb is more potent in mediating both effects. In order to demonstrate the involvement of epitope recognition in these processes, we analyzed sequences in which Ala substituted for Asp9 and Lys10 [AISpreTM(9,10)A] or Trp17 and Phe18 [AISpreTM (17, 18 )A] to control for the specificity of the interaction of the 2F5 and 4E10 Mabs, respectively (Fig. 5) . These substitutions were inspired by alanine-scanning mutagenesis, which pinpointed these residues as crucial for the neutralizing activity of the 2F5 and 4E10 Mabs (87) . The AISpreTM(9,10)A and AISpreTM (17,18)A sequences were therefore designed to produce the VOL. 82, 2008 NAb BLOCKING OF MEMBRANE-ACTIVE HIV-1 SEQUENCES 8991 strongest effect on recognition by only one of the two MAbs, while reducing the effect on the membrane restructuring efficiency of the peptide variants as much as possible. ELISA studies confirmed the failure of the 4E10 MAb to recognize AISpreTM(17,18)A while it efficiently bound to plaques coated with the AISpreTM(9,10)A variant (Fig. 5A) . Likewise, the 2F5 MAb bound to plates coated with AISpre TM(17,18)A but not to plates coated with AISpreTM(9,10)A. We then evaluated the capacity of these MAbs to block the vesicle permeabilization induced by these variants in phosphatidylcholine (POPC)-Chol vesicles (Fig. 5B) . Both MAbs were added at doses that almost completely arrested the process induced by the wild-type AISpreTM (Fig. 5B, insets) . In accordance with specific recognition in membranes, the 4E10 MAb blocked AISpreTM(9,10)A-induced but not AISpreTM (17,18)A-induced leakage. Conversely, the 2F5 MAb induced the opposite effect, and, specifically, it arrested AISpreTM(17, 18)A-induced leakage while it exerted almost no effect on the process induced by the AISpreTM(9,10)A variant. The results of a FACS analysis (Fig. 5C ) confirmed that the membraneblocking activity correlated with MAb-vesicle association. Thus, vesicles labeled with fluorescent antibodies were recovered from a mixture of AISpreTM(17,18)A and MAb 2F5 or AISpreTM(9,10)A and MAb 4E10 but not from samples in which AISpreTM (17, 18) A and MAb 4E10 or AISpreTM(9, 10)A and MAb 2F5 were combined.
DISCUSSION
Gp41 MPER harbors the linear epitopes recognized by the broadly neutralizing 2F5 and 4E10 MAbs (15, 82) . Consequently, MPER-based peptidomimetics have been thoroughly scrutinized as immunogenic candidates (43, 86) . Soluble, conformationally constrained synthetic derivatives (7, 30, 44, 73) or MPER residues inserted into host protein loop sequences (20, 22, 28, 36, 48, 55) almost invariably induce the recovery of epitope-recognizing responses devoid of virus-neutralizing activity. The findings that the MPER PreTM sequence might stably insert and reside at the membrane interface (58, 64, 70, 72) and that both NAbs possess long CDR3 loops of heavy chains (32, 34, 88) bearing exposed hydrophobic-at-interface residues (19, 51, 62) suggest that recognition in the membrane might correlate with neutralizing activity. These observations motivated the analysis of the immunogenic properties of lipidbound spike versions reconstituted on solid-phase liposomes or present in the context of virus-like particles (26, 31, 42, 55) . Even though both NAbs bound with high affinity to envelope glycoproteins in membranes (51) , the immune responses recovered after immunization with these specimens were mainly directed against spike regions outside the MPER (31, 42, 55) , which underlines the relative low immunogenicity of this gp41 stretch (84) .
A yet-unexplored alternative strategy to circumvent this . Implementation of such a strategy requires the prior characterization of the factors conditioning the effective interaction of NAbs with MPER sequences embedded in liposomal membranes. For instance, the physicochemical conditions at the membrane interface region might modulate the recognition process by affecting MPER penetration and/or its surface aggregation, as well as by restricting stable NAb-membrane association. In addition, the transfer into the membrane interface imparts a defined secondary structure to protein sequences that integrate into the lipid bilayers ("partitioning-coupled folding") (35, 78) . The viral external membrane is enriched in Chol and sphingomyelin lipid rafts (2, 3, 12) that modulate membrane interactions of MPER-derived synthetic peptides (39, 59, 75, 77) . Thus, these lipids might be anticipated to play a role in HIV-1-neutralizing activity. Indeed, the 4E10 MAb efficiently recognized a PreTM peptide in POPC membranes containing Chol, but not in those containing sphingomyelin (37) . Moreover, 4E10 bound the PreTM in situ, i.e., without detaching from the membrane (37). The 4E10 MAb was formally shown to recognize membranebound peptide and induce the extraction of membrane-buried W672 and F673 residues, thereby defining the molecular mechanism for this effect (72) . Accordingly, the binding of the 2F5 and 4E10 MAbs to peptide-lipid conjugates was better defined by a two-step (encounter docking) conformational change, while binding to linear epitopes followed a simple-adsorption Langmuir model (1) . It has also been proposed that, as part of its neutralization mechanism, NAb binding to membrane-inserted epitopes would interfere with the fusogenic activity of aromatic-rich MPER sequences by specifically blocking their membrane restructuring activity (37, 72) . We have tested this hypothesis using AISpreTM, a peptide that combined the extended 2F5 and 4E10 epitopes (13, 54) . AISpreTM adopted an ␣-helical structure in the membrane environment, which facilitates its spontaneous incorporation from aqueous solution into membrane particles in which both epitopes were exposed at the bilayer interface. This peptide also retained the capacity of PreTM to interact with and induce membrane restructuring of Chol-containing vesicles. The experiments carried out here formally prove that both MAbs can block the membrane restructuring activity of AISpreTM and that this capacity is correlated with specific epitope recognition and their stable association with membranes.
By FACS and electron microscopy we clearly show that the MAbs do not associate with electrically neutral vesicles devoid of AISpreTM. Thus, the correlation between blocking AISpreTM and stable MAb-vesicle association and the dependence of both effects on specific epitope recognition might be key features of a common mechanism. By contrast, we previously reported the direct, weak association of MAbs with electrically neutral vesicles devoid of peptides (62) . This discrepancy may be explained by having previously measured the association of the MAb with immobilized, highly curved vesicles. The mean diameter of those vesicles is in the range of the bilayer width, which results in the expansion of the external membrane monolayer and may in turn facilitate the insertion of the MAbs incubated with the immobilized vesicles over long periods of time (41) .
The capacity for insertion, in combination with the overall positive charge of paratope surfaces, is also likely to underlie direct binding to anionic phospholipid bilayers, particularly to those containing cardiolipin (CL) and phosphatidylinositol phosphate (1, 8, 11, 27, 61) . Putative autoantigen CL mimicry by MPER and the subsequent control of broadly reactive anti-MPER-producing B cells due to tolerance have been proposed to explain the inability of the HIV-1 gp160 envelope to induce anti-MPER-neutralizing antibodies (27) , although this notion has recently been challenged (63) . Favorable electrostatic association coupled to easier access to the hydrocarbon core might in part explain the direct association with CL membranes. This nonspecific mechanism would be based on the combination within CL of electrostatic polar-head group repulsion with the nonlamellar conical shape (i.e., a cross-sectional area smaller at the phospholipid polar head group than at the acyl chain region) (52) . In contrast, access to the bilayer VOL. 82, 2008 NAb BLOCKING OF MEMBRANE-ACTIVE HIV-1 SEQUENCES 8993
on February 21, 2013 by PENN STATE UNIV http://jvi.asm.org/ core is more restricted in unstressed bilayers based on cylindrical PC-like phospholipids that contain Chol (17) . Our results suggest that MAb insertion in such a context could be achieved only upon specific recognition of membrane-bound epitopes. In summary, it appears that the capacity of the 4E10 and 2F5 MAbs to stably insert into membranes can be observed in anionic bilayers subject to lateral pressure that allows easy access to the hydrocarbon core or in electrically neutral bilayers upon specific recognition of membrane-embedded epitope sequences. Although both MAbs were capable of recognizing membrane-associated AISpreTM and blocking its restructuring activity, the 2F5 MAb was clearly less efficient. The ELISA results indicated that this lower capacity could not be explained by the reduced affinity of the 2F5 MAb for AISpreTM immobilized in plates. Thus, we propose two possible explanations for the differences observed in the presence of lipids. First, assuming that both MAbs act through a common epitope extraction mechanism, membrane interface partitioning-coupled folding might more severely restrict recognition by the 2F5 MAb (see the model in Fig. S3 in the supplemental material). Since the MPER residues K665 and W666 are deeply buried in the 2F5 paratope (51) but are inserted at the level of the interface when membrane bound (72) , these residues must be extracted or reoriented upon 2F5 MAb binding. The crystal structure of the Fab-bound 657EQELLELDKWASLW670 2F5 epitope reveals an N-terminal extended region comprising EQELLEL residues, which is followed by two overlapping type I ␤-turns, one between residues DKWA and the other between residues WASL (51). In contrast, the NMR structure in DPC micelles identifies a helical conformation for the 664DKWA SLW670 2F5 epitope stretch (72) , which according to our predictions and infrared spectroscopy determinations can be extended to include the complete 2F5 epitope. Thus, upon 2F5 MAb binding, the helix organized at the interface has to transit through unordered chain conformations before fitting into the Fab 2F5-bound structure constrained by distinct dihedral angles (see Fig. S3 , left, in the supplemental material). The energy required to unfold the 2F5 epitope chain at the interface might reach Ϸ6 kcal mol Ϫ1 (35) . As such, the extraction of K665/W666 residues is associated with the added penalty of the change in secondary structure at the membrane interface, which adds to the entropic cost of desorption from the mobile hydrophobic environment and further immobilization within the paratope. By contrast, both the membrane-bound and the Fab 4E10-bound epitope sequences are mainly helical (18, 72) . In this case, MAb binding results in desorption reorientation while overall chain conformation is retained (see Fig. S3 , right, in the supplemental material).
Alternatively, the membrane-inserted AISpreTM peptide might not accurately represent the native gp41 structures recognized by 2F5 and/or 4E10 MAbs. Indeed, when the two MAbs are assayed under comparable conditions, the 2F5 MAb consistently shows higher affinity and neutralizing potency than the 4E10 MAb (1, 9) . Moreover, the 2F5 MAb efficiently blocked cell fusion and infection of Moloney murine leukemia virus bearing the 2F5 epitope inserted in the surface subunit, supporting the notion that membrane proximity is not involved in neutralization by 2F5 (53) . Thus, the comparatively lower affinity of the 2F5 MAb reported here could be exclusively attributed to the recognition of membrane-inserted MPER states. This phenomenon might in turn indicate that the native 2F5 epitope structure is more complex than that re-created by the membrane-inserted amphipathic-at-interface AIS helix (46) .
